These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23110215)

  • 1. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors.
    Pathi S; Jutooru I; Chadalapaka G; Nair V; Lee SO; Safe S
    PLoS One; 2012; 7(10):e48208. PubMed ID: 23110215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
    BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
    Jutooru I; Chadalapaka G; Lei P; Safe S
    J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
    Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
    BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.
    Pathi SS; Lei P; Sreevalsan S; Chadalapaka G; Jutooru I; Safe S
    Nutr Cancer; 2011; 63(7):1133-42. PubMed ID: 21919647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
    Pathi S; Li X; Safe S
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
    Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
    Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.
    Jutooru I; Chadalapaka G; Sreevalsan S; Lei P; Barhoumi R; Burghardt R; Safe S
    Exp Cell Res; 2010 Aug; 316(13):2174-88. PubMed ID: 20435036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
    Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
    Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
    Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
    J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
    Sreevalsan S; Safe S
    Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
    Chintharlapalli S; Papineni S; Ramaiah SK; Safe S
    Cancer Res; 2007 Mar; 67(6):2816-23. PubMed ID: 17363604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin decreases specificity protein expression in bladder cancer cells.
    Chadalapaka G; Jutooru I; Chintharlapalli S; Papineni S; Smith R; Li X; Safe S
    Cancer Res; 2008 Jul; 68(13):5345-54. PubMed ID: 18593936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
    Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
    Li X; Pathi SS; Safe S
    BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
    Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
    Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.
    Nair V; Pathi S; Jutooru I; Sreevalsan S; Basha R; Abdelrahim M; Samudio I; Safe S
    Carcinogenesis; 2013 Dec; 34(12):2870-9. PubMed ID: 23803693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity Proteins (Sp) and Cancer.
    Safe S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
    Abdelrahim M; Safe S
    Mol Pharmacol; 2005 Aug; 68(2):317-29. PubMed ID: 15883203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a.
    Del Follo-Martinez A; Banerjee N; Li X; Safe S; Mertens-Talcott S
    Nutr Cancer; 2013; 65(3):494-504. PubMed ID: 23530649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.